Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project ScopeĀ 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.



Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global


Status
colourBlue
titleCurrent Status
Q4 2024 Q1 2025

  • Finalise Stage 1 white paper following public review.Get Stage 2 white paper ready for public reviewWhite paper has been completed and pending publication by the PHUSE Office.



Objectives & Deliverables

TimelinesĀ 
White PaperQ4 2023

Finalise Stage 2 of draft White Paper